Background Angiotensin receptor blockers (ARB s; including candesartan, losartan,
olmesartan and valsartan) are widely used to treat hypertension, heart failure and diabetic …

Objectives To monitor the early effect of a national population screening programme for
abdominal aortic aneurysm in 65-year-old men. Setting The study used national statistics for …

Background Unlike western countries, which have reported distinct decreases in incidence
of ruptured abdominal aortic aneurysm (rAAA) over the last few decades, epidemiologic …

INTRODUCTION: Antiplatelet agents, 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors (statin drugs), angiotensin converting enzyme (ACE) inhibitors, and β-adrenergic …

An evidence gap exists in comparing the effectiveness of angiotensin receptor II blockers
(ARBs) for hypertension with that of angiotensin‐converting enzyme inhibitors (ACEIs). We …

Angiotensin converting enzyme (ACE) inhibitors (ACEIs) are beneficial and are strongly
recommended for patients with acute myocardial infarction (MI) associated with heart failure …

OBJECTIVE: In addition to increased risks for aneurysm-related death, previous studies
have determined that all-cause mortality in abdominal aortic aneurysm (AAA) patients is …

Background Current abdominal aortic aneurysm (AAA) screening in men age 65 might have
limited impact on overall AAA death rates if incidence is moving to older ages. Up‐to‐date …

Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …

Inhibitors of the renin-angiotensin system remain a cornerstone of cardiovascular
pharmacotherapy. Although angiotensin converting enzyme inhibitors (ACEIs) have been …